Feds recover $40M from defunct Quebec vaccine developer Medicago
The federal government says it has recovered $40 million from the now-defunct Quebec-based vaccine developer Medicago, and the intellectual property will remain in Canada under a new firm. The government provided Medicago a $173-million advance in the early days of the COVID-19 pandemic to develop and produce a plant-based vaccine in Quebec City. The company's Japanese parent company, Mitsubishi Chemical Group, shut down Medicago's operations in February as global demand for vaccinations plummeted. Though Medicago's vaccine was approved for use in Canada, it was not approved by the World Healt...
8.85 c
